A Generic EpiPen Coming in Early 2019 Could Save You Money

Brand-name EpiPens at a Congressional hearing on the escalating cost of the drug in 2016
Brand-name EpiPens at a Congressional hearing on the escalating cost of the drug in 2016
Alex Wong/Getty Images

For an incredibly common, life-saving medication, EpiPens (epinephrine auto-injectors) are surprisingly difficult for many consumers to get ahold of. Their cost has skyrocketed in recent years from less than $100 for a pack of two to more than $600. They’ve gotten so expensive that some EMTs have resorted to using syringes to manually administer epinephrine rather than purchasing the standard auto-injectors, which are almost exclusively made by the pharmaceutical company Mylan. Generic options have been slow to come to market, but according to Business Insider, a recently approved EpiPen rival is coming in the first few months of 2019, and it could save consumers a significant chunk of change.

The drug’s developers have had an unusually hard time getting the new EpiPen alternative, called Symjepi, onto store shelves. The drug was approved in 2017, but the company, Adamis Pharmaceuticals, had trouble finding investors. Now, Novartis, the Swiss-based pharmaceutical giant that manufactures drugs like Ritalin, is releasing the drug through its Sandoz division (perhaps most famous for it role in discovering LSD in the 1930s).

Symjepi will cost $250 out-of-pocket for a pack of two doses. That’s 16.6 percent less than the Mylan-authorized generic EpiPen or Teva’s generic EpiPen, which both sell for $300. It differs a bit from its rivals, though, in that it’s a pre-filled, single-dose syringe rather than a spring-loaded auto-injector. Auto-injectors are plastic, pen-like devices that keep the needle shielded until the moment of injection, and are specifically designed to help make it easier for untrained (even squeamish) people to use in an emergency. With this version, patients will need to remove a needle cap and inject the needle. Just like the EpiPen, though, it’s designed to be injected in the upper thigh, through clothing if necessary.

If you have health insurance, the difference in cost may not matter as much for you as a consumer, depending on your plan. (I personally picked up a two-pack of Mylan-authorized generic Epipens at CVS recently for $0, using a manufacturer’s Epipen coupon to knock down what would have been a $10 copay.) But it will matter considerably for those with high-deductible plans and to insurers, which, when faced with high costs, eventually pass those costs on to the consumer either through higher co-pays or higher premiums. It also affects agencies that buy EpiPens for emergency use, like local fire departments. And since EpiPens expire after just a year, the costs add up.

However, there’s currently a shortage of EpiPens on the market, according to the FDA, making it more important than ever to have other epinephrine drugs available to those at risk for serious allergic reactions.

[h/t Business Insider]

Doctors at a British Hospital Are Now Prescribing Houseplants for Depression

Halfpoint/iStock via Getty Images
Halfpoint/iStock via Getty Images

You don’t have to take a trip to the countryside to reap the mental health benefits of being around nature—a single plant might just do the trick (as long as you can keep it alive).

Fast Company reports that the Cornbrook Medical Practice in Manchester, England, is one of the first in the country to prescribe houseplants to help treat anxiety and depression. It’s part of a horticultural therapy program led by a local nonprofit called Sow the City, which leads initiatives to foster community gardens in Manchester.

It’s just as much about building a sense of community through gardening as it is about the therapeutic advantages of caring for your own house plants. “There’s evidence that people who are socially isolated have worse health outcomes,” Sow the City director Jon Ross told Fast Company. The organization has also assisted Cornbrook Medical Practice in establishing its own herb garden, which patients are welcome to help maintain. Ross and his team work closely with doctors at different offices to optimize each garden for its particular clientele—sometimes, that means building a small, flora-filled sanctuary that’s just for rest and relaxation.

Other times, it’s a fully-fledged vegetable garden. For a “Hospital Beds” program at another hospital, Sow the City installed raised vegetable beds where long-term mental illness patients can soak in some sunlight, socialize with each other, and take pride in seeing the fruits (and vegetables) of their labors flourish. There’s an added physical health benefit, too: The patients get to eat the produce. “We really don’t have good food in our public hospitals,” Ross said.

Sow the City also makes sure that no green thumbs are necessary to participate in any gardening party. Its members populate the gardens with already-healthy, easy-to-tend plants, and they’ll even train patients on how to care for them.

If you’re thinking a garden might improve your own quality of life—doctor’s orders or not—here are 10 easy-to-grow plants for first-time gardeners.

[h/t Fast Company]

Illinois Becomes the First State to Require Insurance Companies to Cover EpiPens for Kids

Joe Raedle/Getty Images
Joe Raedle/Getty Images

The ever-changing landscape of the U.S. healthcare system has created difficulties for people who may no longer be able to afford potentially lifesaving medications like EpiPens. The Illinois government decided it was time to step in: Beginning on January 1, 2020, health insurance companies will be required to cover EpiPen costs for children in the state with severe allergic reactions. Tonya Winders, president and CEO of the Allergy & Asthma Network, told CNN that Illinois is the first state to pass such legislation.

CNN reports that Governor J.B. Pritzker officially signed the law, House Bill 3435, which mandates insurance coverage “for epinephrine injectors for persons 18 years of age or under.” Pritzker also tweeted that “this legislation takes a big step forward in protecting our children and families.” Illinois Senator Julie Morrison, who sponsored the initial proposal, echoed the governor’s sentiment in her own statement.

“We should be doing everything we can to expand access to affordable lifesaving drugs and medicines,” Morrison said. “No child with a serious allergy should be without an epinephrine injector because they cannot afford one.”

In 2009, the purchase of two EpiPens would have set you back about $100; by 2016, that number had skyrocketed to $600. During that time, the situation became so dire that some people were opting to fill their own syringes with epinephrine instead, making it more difficult to measure the dose and also administer the injection. Thankfully, the FDA approved a generic version of the EpiPen last year, providing market competition for pharmaceutical company Mylan, which has been manufacturing EpiPens thus far.

EpiPens work by injecting a high dose of epinephrine, or adrenaline, into your bloodstream, which reduces the rapid swelling of your airways during anaphylactic shock. Since allergic reactions can happen so quickly, your life could be seriously threatened if you don’t have an EpiPen nearby at the time of the attack. Wondering what anaphylactic shock looks like from the inside? Find out here.

[h/t CNN]

SECTIONS

arrow
LIVE SMARTER